🇧🇪 Belgium Clinical Trials Database
Search 5,400+ clinical trials conducted in Belgium. Access comprehensive trial data including phases, sponsors, outcomes, and locations from EU Clinical Trials Register. Part of Pure Global AI's free database with 840,000+ trials worldwide.

What is the Belgium clinical trials database?
The Belgium clinical trials database contains over 5,400 clinical trials registered through EU Clinical Trials Register. It includes trials for drugs, medical devices, biologics, and behavioral interventions conducted in Belgium.
How do I search for clinical trials in Belgium?
Enter a disease name, drug name, sponsor, or trial ID in the search box above. You can filter results by phase, status, and intervention type.
What information is available for each trial?
Each trial listing includes: trial ID, study title, phase, status, sponsor, enrollment, start/end dates, disease/condition, intervention, primary outcomes, and location information.
Is this database free to use?
Yes, this database is completely free. Pure Global AI provides free access to clinical trial data to help researchers, patients, and companies find relevant clinical research in Belgium.
How often is the database updated?
The database aggregates data from EU Clinical Trials Register and is updated regularly. The full database contains 840,000+ trials from 20+ registries worldwide.
What regulatory body oversees clinical trials in Belgium?
FAMHP (Federal Agency for Medicines and Health Products) oversees clinical trials in Belgium.
What types of trials are common in Belgium?
Belgium is a major hub for pharmaceutical R&D in Europe, with many global pharma companies having research centers there.
About This Database
This database provides free access to clinical trial data from Belgium. Data is aggregated from EU Clinical Trials Register and international registries. Use this tool to research ongoing trials, find recruitment opportunities, analyze competitive landscape, and track drug/device development. Belgium hosts headquarters for many pharmaceutical companies and has a strong clinical research infrastructure.
